Terkko Navigator / British Journal of Haematology

Beta‐thalassaemia major: Prevalence, risk factors and clinical consequences of hypercalciuria

Peripheral blood CD3+ T‐cell gene expression biomarkers correlate with clinical frailty in patients with haematological malignancies

Feasibility of outpatient administration of axicabtagene ciloleucel and brexucabtagene autoleucel using telemedicine tools: The Vanderbilt experience

Chimeric antigen receptor T‐cell therapy is superior to standard of care as second‐line therapy for large B‐cell lymphoma: A systematic review and meta‐analysis

An eltrombopag‐induced remission of bone‐marrow aplasia accompanied by marked leukoerythroblastosis and splenomegaly

Heterozygous, germline JAK2 E846D substitution as the cause of familial erythrocytosis

The molecular rationale for the combination of polatuzumab vedotin plus rituximab in diffuse large B‐cell lymphoma

Skin manifestations of intravascular adult T‐cell leukaemia/lymphoma

Anti‐SARS‐CoV‐19 antibodies in children and adults with sickle cell disease: A single‐site analysis in New York City

GATA2 deficiency and MDS/AML: Experimental strategies for disease modelling and future therapeutic prospects

Quality of life independently predicts overall survival in myelofibrosis: Key insights from the COntrolled MyeloFibrosis Study with ORal Janus kinase inhibitor Treatment (COMFORT)‐I study

Splicing factor 3B subunit 1 (SF3B1) mutation in the context of therapy‐related myelodysplastic syndromes

Regulatory T cells are replenished in the splenic microenvironment of patients with immune thrombocytopenia by treatment with thrombopoietin receptor agonists

Optimizing haematopoietic stem and progenitor cell apheresis collection from plerixafor‐mobilized patients with sickle cell disease

Asciminib for chronic myeloid leukaemia: Next questions

Blinatumomab as bridging therapy in paediatric B‐cell acute lymphoblastic leukaemia complicated by invasive fungal disease

New biomarker paves the way for a clinical trial for neurodegeneration in Langerhans cell histiocytosis

Practical management of the haemorrhagic complications of myeloproliferative neoplasms

Reduction in seroprevalence of viral transfusion‐transmitted infections in southwest Nigeria in children with sickle cell disease using an enhanced screening strategy

Treatment with obinutuzumab leads to worse outcomes in haematological patients diagnosed with Omicron variant COVID‐19

The clinical influence of preformed nonspecific anti‐HLA antibodies on single‐unit umbilical cord blood transplantation in patients with haematological malignancies

Metabolomic profiling of cerebrospinal fluid reveals an early diagnostic model for central nervous system involvement in acute lymphoblastic leukaemia

Ibrutinib use, treatment duration, and concomitant medications in Australian patients with relapsed or refractory chronic lymphocytic leukaemia

Thrombopoietin receptor agonists increase splenic regulatory T‐cell numbers in immune thrombocytopenia

GOALs in relapsed DLBCL

A rare presentation of a rare disease: cold haemagglutination disease as the first manifestation of IgM myeloma

A biomarker signature to predict complete response to itacitinib and corticosteroids in acute graft‐versus‐host disease

Major haemorrhage: putting evidence into practice

A guideline for the haematological management of major haemorrhage: a British Society for Haematology Guideline

Cytoreductive treatment and association with platelet function and maturity in patients with essential thrombocythaemia

Empagliflozin modulates CD4+ T‐cell differentiation via metabolic reprogramming in immune thrombocytopenia

Early integration of palliative care for patients with haematological malignancies

Retention of functional mitochondria in mature red blood cells from patients with sickle cell disease

Mesenchymal stroma/stem cells: Haematologists’ friend or foe?

The use of next‐generation sequencing in the diagnosis of rare inherited anaemias: A Joint BSH/EHA Good Practice Paper

Menstrual problems in chronic immune thrombocytopenia: A monthly challenge ‐ a cohort study and review

Outcomes of allogeneic haematopoietic cell transplantation for chronic neutrophilic leukaemia: A combined CIBMTR/CMWP of EBMT analysis

Haematological variables and risk of future venous thromboembolism in the British Regional Heart Study on men. Combined D‐dimer and APTT as a predictive test for thromboembolism?

Impaired humoral and cellular response to primary COVID‐19 vaccination in patients less than two years post allogeneic bone marrow transplant

T‐helper cell regulation of CD45 phosphatase activity by galectin‐1 and CD43 governs chronic lymphocytic leukaemia proliferation

The impact of COVID‐19 on related‐donor allogeneic stem cell harvest processes: A British Society of Blood and Marrow Transplantation and Cellular Therapy survey

Sustained sutimlimab response for 3 years in patients with cold agglutinin disease: A phase I, open‐label, extension trial

Identification of seasonal variation in the diagnosis of acute myeloid leukaemia: a population‐based study

Myeloid neoplasms with 8q24/MYC rearrangement are frequently associated with myelodysplasia, complex karyotype, TP53 alterations, and inferior survival

Guidelines for thrombophilia testing: A British Society for Haematology guideline

Favourable outcomes of double‐hit/double‐expressor lymphoma and high‐grade B‐cell lymphoma, not otherwise specified after early dose‐intensive treatment and up‐front autologous stem cell transplantation: a single‐centre retrospective experience

Isocitrate dehydrogenase inhibitors as a bridge to allogeneic stem cell transplant in relapsed or refractory acute myeloid leukaemia

Limited activity of fedratinib in myelofibrosis patients relapsed/refractory to ruxolitinib 20 mg twice daily or higher: A real‐world experience

Clinical implications and genetic features of clonal cytopenia of undetermined significance compared to lower‐risk myelodysplastic syndrome

Unanswered questions in cancer‐associated thrombosis